Labshake search
Citations for Tocris :
101 - 150 of 262 citations for Human Gastrin Cholecystokinin Type B Receptor CCKBR ELISA Kit since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Neuroscience 2021Quote: ... and 100 μM picrotoxin – GABAA receptor channel blocker (all from Tocris Bioscience, UK). This cocktail prevented filed potential mediated component of astrocytic current and largely reduced IK (Shih et al. ...
-
bioRxiv - Neuroscience 2020Quote: ... and 100 μM picrotoxin – GABAA receptor channel blocker (all from Tocris Bioscience, UK). This prevented filed potential mediated component of astrocytic current and largely reduced IK (Shih et al. ...
-
bioRxiv - Neuroscience 2020Quote: ... or the D1 receptor antagonist SCH 23390 hydrochloride (Tocris Bioscience, cat no: 0925) at a dose of 0.01 or 0.2 mg/kg ...
-
bioRxiv - Neuroscience 2019Quote: ... and the D1/D2 receptor co-agonist SKF 83959 (10–50 µM; Tocris). For dopamine receptor antagonists we used the D1-like antagonist SCH-23390 (10 µM ...
-
bioRxiv - Physiology 2020Quote: ... injected with the dopamine receptor D2 (DRD2) agonist cabergoline (0.5 mg/kg, Tocris) or saline at 11:00 am ...
-
bioRxiv - Neuroscience 2021Quote: ... and glutamate receptors (NBQX, 10 μM, Tocris; and DL-AP5, 30 μM, Sigma).
-
bioRxiv - Neuroscience 2023Quote: ... The DREADD receptor was activated by intraperitoneal injection of clozapine (0.005mg/kg; Tocris) 5-10 minutes prior to the start of the experiment47,48 ...
-
bioRxiv - Neuroscience 2023Quote: ... 5-HT7 receptor agonist (10-5M AS-19, Tocris, CAS:1000578-26-6). The stock solutions of these drugs were diluted in extracellular physiological saline which contained ...
-
bioRxiv - Neuroscience 2023Quote: ... 5-HT7 receptor antagonist (10-5M Sb 258719, Tocris, CAS:1217674-10-6), 5-HT7 receptor agonist (10-5M AS-19 ...
-
bioRxiv - Neuroscience 2023Quote: ... NMDA- and GABAA- receptors was carried out by using CNQX (10 μM, Tocris), AP-5 (40 μM ...
-
bioRxiv - Neuroscience 2020Quote: ... Dynorphin B (100-200 nM; Tocris) and Kisspeptin (100 nM ...
-
bioRxiv - Cancer Biology 2023Quote: Centrinone B (Tocris Bioscience #5690/10), Alexa Fluor™ 488 Phalloidin (Invitrogen #A12379) ...
-
bioRxiv - Developmental Biology 2023Quote: Cytochalasin B 20ug/mL (Tocris 5474). DMSO (Sigma D5879)
-
bioRxiv - Developmental Biology 2023Quote: ... Cytochalasin B (10 µM; Tocris Bioscience), and Y-27632 (10 µM ...
-
bioRxiv - Neuroscience 2020Quote: ... the GABAA receptor antagonist gabazine (SR 95531 hydrobromide, Tocris, Wiesbaden-Nordenstadt, Germany, 5 μM) was bath-applied for 60 min after having recorded a minimum of 20 min stable baseline responses ...
-
bioRxiv - Neuroscience 2020Quote: ... the reversal potential and the effect of receptor antagonists [10 μM NBQX (Tocris Bioscience) or 20 μM bicuculline (BIC ...
-
bioRxiv - Neuroscience 2022Quote: ... and the selective NMDA receptor antagonist amino-5-phosphonopentanoic acid (AP5; 50 μM, Tocris).
-
All-optical interrogation of a direction selective retinal circuit by holographic wave front shapingbioRxiv - Neuroscience 2019Quote: ... and the metabotropic glutamate receptor agonist LAP4 (20 μM, catalog no 0103, Tocris Bioscience). The retina was left to rest in the dark for ~ 30-45 min ...
-
bioRxiv - Neuroscience 2020Quote: ... we also added the glutamate receptor antagonists NBQX and CPP (both 10 µM, Tocris). For current-clamp recordings with putative muscarinic receptor-mediated currents ...
-
bioRxiv - Neuroscience 2022Quote: ... and L-2-amino-5-phosphonopentanoic acid (APV, an NMDA receptor blocker) from Tocris. APV ...
-
bioRxiv - Neuroscience 2023Quote: ... the reversal potential and the effect of receptor antagonists [10 μM NBQX (Tocris Bioscience) or 20 μM bicuculline (BIC ...
-
bioRxiv - Neuroscience 2024Quote: ... while block of GABAB receptors was performed by application of 25μM CGP 46381 (Tocris). The locations of each patched cell were logged and displayed in the Figures.
-
bioRxiv - Immunology 2020Quote: ... cathepsin B inhibitor MDL 28170 (Tocris Bioscience) at 0.1 μM ...
-
bioRxiv - Systems Biology 2022Quote: ... cells were treated with Pladienolide B (Tocris) 24 hours prior to irradiation ...
-
bioRxiv - Neuroscience 2021Quote: ... glutamate and GABA receptor blockers (10 μM NBQX, Tocris, UK, 1044; 5 μM CPP, Tocris, 0247 ...
-
bioRxiv - Neuroscience 2022Quote: ... We bath-applied the following drugs: picrotoxin (PTX) (GABAA receptor antagonist, 10µM, Tocris Bioscience, #1128) and strychnine hydrochloride (Strych ...
-
bioRxiv - Neuroscience 2019Quote: ... For dopamine receptor antagonists we used the D1-like antagonist SCH-23390 (10 µM; Tocris); the D2-like antagonists sulpiride (20 µM ...
-
bioRxiv - Neuroscience 2020Quote: Designer receptor-ligand clozapine-N-oxide (CNO, Tocris Bioscience; 4936, CAS No: 34233-69-7) was dissolved in 0.9 % saline solution at a concentration of 0.1 mg/ml and administered i.p ...
-
bioRxiv - Neuroscience 2022Quote: ... mEPSCs were recorded in the presence of 3 μM AMPA receptor antagonist NBQX (Tocris Bioscience) in standard external solution.
-
bioRxiv - Cell Biology 2023Quote: ... or 10 μM TGFB receptor inhibitors including SB525334 (Selleckchem S1476) and A83-01 (Tocris 2939) were prepared according to the supplier’s instructions ...
-
bioRxiv - Neuroscience 2023Quote: ... GABAA and glycinergic receptor-mediated synaptic transmission was blocked using 50 μM picrotoxin (Tocris Bioscience), which was prepared from a 100 mM stock solution containing DMSO (final DMSO concentration ...
-
bioRxiv - Cancer Biology 2021Quote: ... Pladienolide B and SRPIN340 were purchased from Tocris.
-
bioRxiv - Cell Biology 2022Quote: ... Conduritol B epoxide (CBE) was procured from Tocris Bioscience ...
-
bioRxiv - Biochemistry 2023Quote: ... B-HT 933 dihydrochloride (α2 adrenergic agonist, TOCRIS), DL-isoproterenol hydrochloride (non-selective β adrenergic agonist ...
-
bioRxiv - Cell Biology 2023Quote: ... or 60 nM latrunculin B (Tocris, Bristol, UK) for 2 h prior to experiments ...
-
bioRxiv - Neuroscience 2020Quote: ... Substance P was manipulated by injecting the agonist of the NK-1 receptor Substance P (Tocris) to an estimated final concentration of 200 nM ...
-
bioRxiv - Neuroscience 2022Quote: ... to block ionotropic gamma-amino-butyric acid receptors (GABAARs) and 10 μM NBQX (1044, Tocris Biosciences) to inhibit α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors (AMPARs) ...
-
bioRxiv - Neuroscience 2021Quote: ... was dissolved in HEPES-aCSF in the presence of non-mGluR glutamate receptor blockers (CNQX, Tocris, 0190 ...
-
bioRxiv - Neuroscience 2021Quote: ... 3-((±)2-carboxypiperazin-4yl) propyl-1-phosphate (CPP, NMDA receptor antagonist, 20 μM; Tocris Bioscience, UK) and 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX ...
-
bioRxiv - Neuroscience 2022Quote: ... we slowly infused 200 nl of the GABAA receptor agonist muscimol (Tocris; 2 μM in saline) into the target area using a micro-syringe pump (KD Scientific ...
-
bioRxiv - Neuroscience 2023Quote: ... was dissolved in HEPES-aCSF in the presence of non-mGluR glutamate receptor blockers (CNQX, Tocris, 0190 ...
-
bioRxiv - Neuroscience 2023Quote: ... were dissolved in HEPES-aCSF in the presence of non-NMDA glutamate receptor blockers (CNQX, Tocris, 0190 ...
-
bioRxiv - Animal Behavior and Cognition 2023Quote: ... As a positive control we used potent agonist of CB1 and CB2 receptors CP55,940 (Tocris, UK). All doses were selected based on our previously published experiments46,50 ...
-
bioRxiv - Neuroscience 2023Quote: ... neural medium was additionally supplemented with retinoid X receptor agonist SR 11237 (100 nM; Tocris, 3411). From day 22 ...
-
bioRxiv - Neuroscience 2021Quote: ... Type I mGluR agonist DHPG (Tocris, 0805; 100 μM) was dissolved in HEPES-aCSF in the presence of non-mGluR glutamate receptor blockers (CNQX ...
-
bioRxiv - Neuroscience 2023Quote: ... Type I mGluR agonist DHPG (Tocris, 0805; 100 µM) was dissolved in HEPES-aCSF in the presence of non-mGluR glutamate receptor blockers (CNQX ...
-
bioRxiv - Bioengineering 2019Quote: ... at 2μM and at 4μM and by blocking the RyR receptors using Ryanodine (Tocris, cat no. 1329). at 10μM ...
-
bioRxiv - Neuroscience 2021Quote: ... IP3 receptors were blocked by bath application of 2-APB (100 µM, Tocris, Germany, micro-perfusion pump), 2-APB was applied at least 15 min prior t-LTP induction and was present throughout the recordings ...
-
bioRxiv - Neuroscience 2020Quote: ... EPSCs were induced in the presence of the competitive AMPA receptor antagonist NBQX (3 μM, Tocris Bioscience). Paired-Pulse stimulation for excitatory autapses was assessed by the induction of 2 action potentials with an interstimulus interval of 25 ms ...
-
bioRxiv - Neuroscience 2022Quote: ... To monitor acute changes in [Cl-]i we bath applied GABAA receptor agonist muscimol (Tocris, 10 μM) and imaged at lower resolution (every 2 minutes at a resolution of 4.1 pixels/μm (512×512 pixels ...